These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 30844025)
1. Unintended Consequences of the Right to Try Act for Palliative Care in Pediatric Oncology. Lanzel AF; Lavery JV JAMA Oncol; 2019 May; 5(5):603-604. PubMed ID: 30844025 [No Abstract] [Full Text] [Related]
2. Pediatric Trials for Cancer Therapies With Targets Potentially Relevant to Pediatric Cancers. Hwang TJ; Orenstein L; DuBois SG; Janeway KA; Bourgeois FT J Natl Cancer Inst; 2020 Mar; 112(3):224-228. PubMed ID: 31665394 [TBL] [Abstract][Full Text] [Related]
3. [Legal issues in the off-label use of drug medication in in pediatrics]. Poetsch J J Dtsch Dermatol Ges; 2006 May; 4(5):421-6. PubMed ID: 16686611 [No Abstract] [Full Text] [Related]
4. Promoting Patient Interests in Implementing the Federal Right to Try Act. Lynch HF; Zettler PJ; Sarpatwari A JAMA; 2018 Sep; 320(9):869-870. PubMed ID: 30105394 [No Abstract] [Full Text] [Related]
6. EU law mandates drug testing in children. Sinha G J Natl Cancer Inst; 2008 Jan; 100(2):84-5. PubMed ID: 18182609 [No Abstract] [Full Text] [Related]
10. Federal Right-to-Try Legislation - Threatening the FDA's Public Health Mission. Joffe S; Lynch HF N Engl J Med; 2018 Feb; 378(8):695-697. PubMed ID: 29320302 [No Abstract] [Full Text] [Related]
11. Long-term care: end-of-life issues. End-of-year issue brief. Jones CA; Miller KG Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345562 [No Abstract] [Full Text] [Related]
12. The impact of the written request process on drug development in childhood cancer. Snyder KM; Reaman G; Avant D; Pazdur R Pediatr Blood Cancer; 2013 Apr; 60(4):531-7. PubMed ID: 23335552 [TBL] [Abstract][Full Text] [Related]
13. Palliative care in pediatric patients with hematologic malignancies. Humphrey L; Kang TI Hematology Am Soc Hematol Educ Program; 2015; 2015():490-5. PubMed ID: 26637763 [TBL] [Abstract][Full Text] [Related]
15. Current status of pediatric hematology/oncology and palliative care in Lebanon: a physician's perspective. Noun P; Djambas-Khayat C J Pediatr Hematol Oncol; 2012 Mar; 34 Suppl 1():S26-7. PubMed ID: 22357148 [TBL] [Abstract][Full Text] [Related]
16. Ethical and legal issues in palliative care. McCabe MS; Coyle N Semin Oncol Nurs; 2014 Nov; 30(4):287-95. PubMed ID: 25361881 [TBL] [Abstract][Full Text] [Related]
17. Pediatric marketing exclusivity--as altered by the Best Pharmaceuticals for Children Act of 2002. Cooper KJ Food Drug Law J; 2002; 57(3):519-44. PubMed ID: 12710409 [No Abstract] [Full Text] [Related]
18. Paediatric Oncology at the Crossroads: A Call for Change. Rose K Pharmaceut Med; 2020 Oct; 34(5):297-300. PubMed ID: 33026589 [No Abstract] [Full Text] [Related]
19. American society of clinical oncology--41st annual meeting. Immunology. Shah S; Yager N IDrugs; 2005 Jul; 8(7):528-30. PubMed ID: 15973554 [No Abstract] [Full Text] [Related]
20. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer. Rose K Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]